What does it really take to bring a biotech product to market?

Nigel Theobald, founder and CEO of N4 Pharma, joins me to share the real highs and lows of turning science into a scalable business.

We dive into:

• The challenges of RNA drug delivery

• How to stay resilient when plans change

• Building a virtual, world-class team

• The path from platform to product

This is a must-listen for anyone in biotech, medtech, or startup life.

📺 Watch on Youtube:https://youtu.be/Jy1JA5J1-F8

📝 Join the mailing list to get the show notes forevery episode here: https://thesalesaccelerationformula.com/podcast-show-notes

Today, we’re diving into how funding for digital health has plummeted 3× since 2021, yet Tamar Blue still raised over $1 million for her mental-health startup, MentalHappy.

Stick around for her exact playbook, complete with action challenges you can use today.

Let’s get started!

📝 Join the mailing list to get the show notes forevery episode here: https://thesalesaccelerationformula.com/podcast-show-notes

Digital-health cash is scarce, yet Tamar Blue secured > $1 M for MentalHappy.

Hear her fundraising tactics, user-validation hacks, and the 12-year mindset every founder needs.

Perfect for med-tech builders hungry for traction.

📺 Watch on Youtube: https://youtu.be/kKKdaepF0Og

📝 Join the mailing list to get the show notes forevery episode here: https://thesalesaccelerationformula.com/podcast-show-notes

"In this 5-in-5 episode of The H-Files, we review the key takeaways from my podcast with MedTech entrepreneur Spencer Jones to break down 5 practical ways AI is transforming how we build and scale MedTech businesses.

From FDA submissions to ROI calculators, these aren’t hypotheticals, they’re real-world strategies you can apply today.

Hit play and discover how to save time, scale smarter, and stay competitive using AI."

In this episode of The H-Files, Hakeem is joined by returning guest Spencer Jones to dive into the real-world applications of AI in building and scaling MedTech businesses.
From cutting regulatory prep time in half to identifying top KOLs across Europe, Spencer walks through the exact tools and workflows he uses to supercharge productivity, speed, and innovation.

🎯 Perfect for MedTech founders, innovators, and healthcare consultants ready to future-proof their strategy.

🎥 Watch the full video on YouTube to see Spencer’s live tool demos in action. https://youtu.be/OMY9XFQqSYI

📝 Join the mailing list to get the show notes forevery episode here: https://thesalesaccelerationformula.com/podcast-show-notes

Tools used :

Claude (Anthropic)

AskSteve.ai

Vercel V0

MedTechVendors.com

⁠Perplexity AI⁠

In this 5-in-5 episode, I unpack my conversation with Lee Ali, MD of Expo Stars and international exhibition expert.
We break down how most MedTech companies waste tens of thousands at global healthcare events—and what to do instead.
From qualifying leads to energising your team, this is your no-fluff guide to making every trade show count.
Five key insights. Five minutes. One smarter conference strategy.

Too many companies show up to healthcare exhibitions, but few stand out.

This week on The H-Files, I sit down with Lee Ali, founder of Expo Stars, to explore what turns a passive booth into a powerful business engine.

From the TEO framework to practical tips on team structure and lead conversion, this is a must-listen for anyone serious about turning trade show presence into real ROI.

📺 Watch on Youtube: https://youtu.be/jDd7soQ7rRg

📝 Join the mailing list to get the show notes forevery episode here: https://thesalesaccelerationformula.com/podcast-show-notes

Welcome to The H-Files: 5-in-5, the weekly dose of distilled insight from healthcare leaders — in five minutes or less.
In this episode, I reflect on my conversation with Dave Taylor, CEO of Valley Diagnostics, who's navigating the hard road of building a medtech company from scratch.
We cover five key lessons — from funding dilemmas and NHS barriers, to vision, values, and health economics plus one action step you can take right now for each.
Whether you’re an innovator, founder, or investor , this one’s for you.